News
The Food and Drug Administration (FDA)'s Center for Devices and Radiological health (CDRH) recently launched the READI-Home (Reducing Readmissions through Device Innovation for the Home) Innovation Challenge, part of its broader Home as a Health Care Hub initiative, to accelerate development of
Inventors at the National Institute of Dental and Craniofacial Research (NIDCR) are searching for a collaboration partner for a tissue engineering method for treating cartilage damage. Currently, there are no effective treatment options approved to prevent arthritis progression. This method involves
The Public Health and Economic Impact Study of NIH Intramural Technology Transfer Licensing final project report has been published. This report dives into the history of biomedical innovations that were a result of the NIH Intramural Research Program (IRP) that benefit the United States. This
A novel anti-cancer therapy to target the Proviral Integration of the Moloney murine leukemia virus (PIM) kinases is available for licensing and co-development. PIM kinases are overexpressed in many solid cancers, which is predictive of poor survival in multiple cancer types. NIH inventors have